EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Timeliness of Care for Transferred and Directly Admitted Patients With Anticoagulation‐Associated Intracerebral Hemorrhage

Regina Royan iD, Jeffrey L Saver iD, Nicole Solomon iD, Brooke Alhanti iD, Brian Stamm iD, Steven R Messe iD, Ying Xian iD, Deepak L Bhatt iD, Raymond C Chang, Ilya Danelich, Joanna Huang, Lee H Schwamm iD und 6 weitere

Journal of the American Heart Association · 2026

DOI: 10.1161/jaha.125.043223 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of the American Heart Association, 2026. Verfasst von Regina Royan und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine University of Michigan Ann Arbor MI USA. Hauptthemen laut MEDLINE: Cerebral Hemorrhage, Anticoagulants, Patient Transfer, Time-to-Treatment. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with anticoagulation‐associated intracerebral hemorrhage are often transferred from the presenting hospital to one with additional resources. Understanding differences in timeliness and care, including anticoagulant reversal, between transfer and direct admissions may identify quality improvement opportunities.

Methods

This cross‐sectional study included all hospitals in the American Heart Association GWTG–Stroke (Get With The Guidelines–Stroke) registry where anticoagulant reversal was administered (2015–2021). Patients with anticoagulation‐associated intracerebral hemorrhage presenting within 24 hours of onset and with information on prior AC treatment were included. Outcomes included functional score at discharge, in‐hospital death/discharge to hospice, discharge ambulatory status, discharge destination, and length of stay.

Results

Of 30 590 patients with AC‐ICH, 14 882 (48.6%) were transfers. Symptom onset to AC reversal was longer for transfer patients who received anticoagulant reversal at the admitting hospital versus direct‐admission patients (512 [interquartile range 328–840] versus 273 [interquartile range, 153–579] minutes; absolute standardized mean difference, 75.9%). Transfer patients had milder stroke severity on admission versus direct‐admission patients on the basis of National Institute of Health Stroke Scale (7 [interquartile range, 2–19] versus 11 [interquartile range, 3–22]; absolute standardized mean difference, 21.2%) and intracerebral hemorrhage scores (1.81±1.36 versus 2.02±1.47; absolute standardized mean difference, 13.7%). In an adjusted logistic regression model, transfer patients had lower odds of in‐hospital death/discharge to hospice (adjusted odds ratio, 0.78 [95% CI, 0.72–0.85]), but no difference in discharge functional score, ambulatory status, or discharge home versus direct‐admission patients.

Conclusions

Transfer patients with anticoagulation‐associated intracerebral hemorrhage had longer times to reversal at the admitting hospital, less severe intracerebral hemorrhage, and lower odds of in‐hospital death versus direct‐admission patients after adjustment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cerebral HemorrhageAnticoagulantsPatient TransferTime-to-TreatmentPatient AdmissionHumansFemaleMaleCross-Sectional StudiesAgedTime FactorsRegistriesAged, 80 and overHospital MortalityUnited StatesMiddle AgedPatient DischargeLength of Stay

Stichwörter der Autor:innen

anticoagulation‐associated intracerebral hemorrhagedeathdirect admissionreversaltransfer

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Department of Emergency Medicine University of Michigan Ann Arbor MI USA.
  • Institute for Healthcare Policy and Innovation University of Michigan Ann Arbor MI USA.
  • Department of Neurology University of Michigan Ann Arbor MI USA.
  • Department of Neurology University of California at Los Angeles Medical Center Los Angeles CA USA.
  • Duke Clinical Research Institute Duke University School of Medicine Durham NC USA.
  • Lt. Col. Charles S. Kettles VA Medical Center Ann Arbor MI USA.

ORCID-Profile: Regina Royan, Jeffrey L Saver, Nicole Solomon, Brooke Alhanti, Brian Stamm, Steven R Messe, Ying Xian, Deepak L Bhatt, Lee H Schwamm, Eric E Smith, Joshua N Goldstein, Brian Mac Grory, Adam H de Havenon, Gregg C Fonarow, Kevin N Sheth

Zitieren

APA

Royan, R., Saver, J. L., Solomon, N., Alhanti, B., Stamm, B., Messe, S. R., Xian, Y., Bhatt, D. L., Chang, R. C., Danelich, I., Huang, J., Schwamm, L. H., Smith, E. E., Goldstein, J. N., Mac Grory, B., de Havenon, A. H., Fonarow, G. C., & Sheth, K. N. (2026). Timeliness of Care for Transferred and Directly Admitted Patients With Anticoagulation‐Associated Intracerebral Hemorrhage. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.043223

Vancouver

Royan R, Saver JL, Solomon N, Alhanti B, Stamm B, Messe SR, et al. Timeliness of Care for Transferred and Directly Admitted Patients With Anticoagulation‐Associated Intracerebral Hemorrhage. Journal of the American Heart Association. 2026. doi:10.1161/jaha.125.043223

BibTeX
@article{Royan2026,
  author = {Royan, Regina and Saver, Jeffrey L and Solomon, Nicole and Alhanti, Brooke and Stamm, Brian and Messe, Steven R and Xian, Ying and Bhatt, Deepak L and Chang, Raymond C and Danelich, Ilya and Huang, Joanna and Schwamm, Lee H and Smith, Eric E and Goldstein, Joshua N and Mac Grory, Brian and de Havenon, Adam H and Fonarow, Gregg C and Sheth, Kevin N},
  title = {Timeliness of Care for Transferred and Directly Admitted Patients With Anticoagulation‐Associated Intracerebral Hemorrhage},
  journal = {Journal of the American Heart Association},
  year = {2026},
  doi = {10.1161/jaha.125.043223}
}
Kostenlos starten →